Expression Table for this CRE
| CNhs14498 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 44.1 |
| CNhs14573 | Myoblast differentiation to myotubes, day06, control donor2 | 16.5 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 9.9 |
| CNhs12079 | Pericytes, donor2 | 9.6 |
| CNhs12998 | testis, adult, pool2 | 9.0 |
| CNhs14519 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1 | 8.7 |
| CNhs12376 | mesenchymal precursor cell - ovarian cancer left ovary, donor3 | 8.3 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 8.2 |
| CNhs12375 | mesenchymal precursor cell - ovarian cancer right ovary, donor2 | 6.6 |
| CNhs12064 | Anulus Pulposus Cell, donor2 | 6.5 |
| CNhs12466 | K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1 | 6.0 |
| CNhs14494 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1 | 6.0 |
| CNhs12659 | MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 5.7 |
| CNhs12953 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 5.4 |
| CNhs12654 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 5.2 |
| CNhs12045 | Smooth Muscle Cells - Coronary Artery, donor3 | 5.2 |
| CNhs12660 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 5.1 |
| CNhs14491 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1 | 4.8 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 4.4 |
| CNhs14497 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 4.2 |
| CNhs12734 | Fibroblast - Conjunctival, donor3 | 4.1 |
| CNhs11676 | uterus, adult, pool1 | 4.1 |
| CNhs14489 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 4.1 |
| CNhs12703 | MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3 | 3.9 |
| CNhs12954 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 3.9 |
| CNhs14493 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 3.8 |
| CNhs12684 | K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 3.7 |
| CNhs12075 | Hepatic Sinusoidal Endothelial Cells, donor1 | 3.7 |
| CNhs12657 | MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 3.7 |
| CNhs11371 | Adipocyte - subcutaneous, donor2 | 3.6 |
| CNhs14488 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 3.5 |
| CNhs11677 | salivary gland, adult, pool1 | 3.5 |
| CNhs12520 | promyelocytes/myelocytes PMC, donor1 | 3.4 |
| CNhs11716 | papillary adenocarcinoma cell line:8505C | 3.3 |
| CNhs12665 | MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 3.3 |
| CNhs12667 | MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2 | 3.2 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 3.2 |
| CNhs12662 | MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 3.2 |
| CNhs11725 | argyrophil small cell carcinoma cell line:TC-YIK | 3.0 |
| CNhs11722 | leiomyoma cell line:10964C | 3.0 |
| CNhs12398 | Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction) | 3.0 |
| CNhs12656 | MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 3.0 |
| CNhs12655 | MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 2.9 |
| CNhs13480 | immature langerhans cells, donor2 | 2.9 |
| CNhs14579 | Myoblast differentiation to myotubes, day02, control donor3 | 2.8 |
| CNhs12692 | K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2 | 2.8 |
| CNhs12119 | Alveolar Epithelial Cells, donor3 | 2.8 |
| CNhs13541 | CD14+CD16+ Monocytes, donor1 | 2.8 |
| CNhs12733 | Retinal Pigment Epithelial Cells, donor3 | 2.8 |
| CNhs12432 | MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1 | 2.7 |